| Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma MF Moffatt, M Kabesch, L Liang, AL Dixon, D Strachan, S Heath, ... Nature 448 (7152), 470-473, 2007 | 1959 | 2007 |
| A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised … MP Boyle, SC Bell, MW Konstan, SA McColley, SM Rowe, E Rietschel, ... The lancet Respiratory medicine 2 (7), 527-538, 2014 | 519 | 2014 |
| Allergy testing in children: why, who, when and how? A Höst, S Andrae, S Charkin, C Diaz‐Vazquez, S Dreborg, PA Eigenmann, ... Allergy 58 (7), 559-569, 2003 | 385 | 2003 |
| Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial E Kerem, MW Konstan, K De Boeck, FJ Accurso, I Sermet-Gaudelus, ... The Lancet Respiratory Medicine 2 (7), 539-547, 2014 | 375 | 2014 |
| Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria H Sidhu, B Hoppe, A Hesse, K Tenbrock, S Bromme, E Rietschel, ... The Lancet 352 (9133), 1026-1029, 1998 | 277 | 1998 |
| Guideline for acute therapy and management of anaphylaxis: S2 guideline of the German Society for Allergology and clinical immunology (DGAKI), the association of German … J Ring, K Beyer, T Biedermann, A Bircher, D Duda, J Fischer, F Friedrichs, ... Allergo journal international 23, 96-112, 2014 | 257 | 2014 |
| Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis K Paul, E Rietschel, M Ballmann, M Griese, D Worlitzsch, J Shute, C Chen, ... American journal of respiratory and critical care medicine 169 (6), 719-725, 2004 | 236 | 2004 |
| Pharmacokinetics of inhaled colistin in patients with cystic fibrosis F Ratjen, E Rietschel, D Kasel, R Schwiertz, K Starke, H Beier, ... Journal of Antimicrobial Chemotherapy 57 (2), 306-311, 2006 | 226 | 2006 |
| Provoking allergens and treatment of anaphylaxis in children and adolescents–data from the anaphylaxis registry of German‐speaking countries S Hompes, A Köhli, K Nemat, K Scherer, L Lange, F Rueff, E Rietschel, ... Pediatric allergy and immunology 22 (6), 568-574, 2011 | 222 | 2011 |
| Triggers and treatment of anaphylaxis: an analysis of 4000 cases from Germany, Austria and Switzerland M Worm, O Eckermann, S Dölle, W Aberer, K Beyer, T Hawranek, ... Deutsches Ärzteblatt International 111 (21), 367, 2014 | 217 | 2014 |
| Meta-analysis identifies seven susceptibility loci involved in the atopic march I Marenholz, J Esparza-Gordillo, F Rüschendorf, A Bauerfeind, ... Nature communications 6 (1), 8804, 2015 | 177 | 2015 |
| Muscle analysis by measurement of maximal isometric grip force: new reference data and clinical applications in pediatrics F Rauch, CM Neu, G Wassmer, B Beck, G Rieger-Wettengl, E Rietschel, ... Pediatric research 51 (4), 505-510, 2002 | 161 | 2002 |
| Prospective evaluation of emerging bacteria in cystic fibrosis G Steinkamp, B Wiedemann, E Rietschel, A Krahl, J Gielen, H Bärmeier, ... Journal of cystic fibrosis 4 (1), 41-48, 2005 | 143 | 2005 |
| Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis M Griese, J Ramakers, A Krasselt, V Starosta, S Van Koningsbruggen, ... American journal of respiratory and critical care medicine 169 (7), 822-828, 2004 | 142 | 2004 |
| Davos declaration: allergy as a global problem J Ring, C Akdis, H Behrendt, RP Lauener, G Schäppi, M Akdis, ... Allergy 67 (2), 141-143, 2012 | 127 | 2012 |
| Akuttherapie anaphylaktischer Reaktionen ÄDA ÄDA Allergo Journal 16, 420-34, 2007 | 123 | 2007 |
| Unifying candidate gene and GWAS Approaches in Asthma S Michel, L Liang, M Depner, N Klopp, A Ruether, A Kumar, M Schedel, ... PloS one 5 (11), e13894, 2010 | 120 | 2010 |
| Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis M Griese, R Essl, R Schmidt, E Rietschel, F Ratjen, M Ballmann, K Paul American journal of respiratory and critical care medicine 170 (9), 1000-1005, 2004 | 119 | 2004 |
| DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha F Ratjen, K Paul, S Van Koningsbruggen, S Breitenstein, E Rietschel, ... Pediatric pulmonology 39 (1), 1-4, 2005 | 115 | 2005 |
| Leitlinie zu Akuttherapie und Management der Anaphylaxie J Ring, K Beyer, T Biedermann, A Bircher, D Duda, J Fischer, F Friedrichs, ... Allergologie 38 (3), 2015 | 109 | 2015 |
